BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2567191)

  • 1. Peripheral blood stem cell autotransplantation in treatment of childhood cancer.
    Watanabe T; Takaue Y; Kawano Y; Koyama T; Huq MA; Shimokawa T; Ninomiya T; Aga Y; Inai T; Hino M
    Bone Marrow Transplant; 1989 May; 4(3):261-5. PubMed ID: 2567191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recovery kinetics of hematopoiesis after peripheral blood stem cell autotransplantation].
    Takaue Y; Watanabe T; Kawano Y; Abe T; Suzue T; Satoh J; Kamata K; Huq MA; Ninomiya T; Kuroda Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):781-6. PubMed ID: 2565703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autografts with peripheral blood stem cells].
    Takaue Y; Ninomiya T
    Rinsho Ketsueki; 1990 May; 31(5):609-13. PubMed ID: 1975630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    Suzue T; Takaue Y; Watanabe A; Kawano Y; Watanabe T; Abe T; Kuroda Y; Matsushita T; Kikuta A; Iwai A
    Exp Hematol; 1994 Nov; 22(12):1197-202. PubMed ID: 7523170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
    Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
    Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute nonlymphoblastic leukemia.
    To LB; Dyson PG; Branford AL; Haylock DN; Kimber RJ; Juttner CA
    Exp Hematol; 1987 May; 15(4):351-4. PubMed ID: 2883016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Mahmut N; Katayama Y; Takenaka K; Teshima T; Ohno Y; Imajyo K; Hara M; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Int J Hematol; 1999 Jan; 69(1):36-42. PubMed ID: 10641441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.
    Sheridan WP; Begley CG; To LB; Grigg A; Szer J; Maher D; Green MD; Rowlings PA; McGrath KM; Cebon J
    Bone Marrow Transplant; 1994 Jul; 14(1):105-11. PubMed ID: 7524904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful blood stem cell collection and transplant in children weighing less than 25 kg.
    Deméocq F; Kanold J; Chassagne J; Bezou MJ; Lutz P; deLumley L; Philip I; Vannier JP; Margueritte G; Lamagnére JP
    Bone Marrow Transplant; 1994 Jan; 13(1):43-50. PubMed ID: 7912601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
    del Cañizo C; Lopez N; Caballero D; Fernandez E; Brufau A; Vazquez L; Mateos V; Gutierrez N; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(9):901-5. PubMed ID: 10338045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.